Serina Therapeutics, Inc. (SER) › Net IncomeSerina Therapeutics, Inc. (SER) — Net IncomeAnnual figures by fiscal year, from SEC filings.2017: -$6.58M2018: -$7.50M2019: -$12.15M2020: -$10.87M2021: -$8.68M2022: -$10.46M2023: $5.27M2024: -$11.14M2025: -$19.18M-$19.18M2017Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$19.18M-72.2%2024-$11.14M-311.4%2023$5.27M+150.4%2022-$10.46M-20.6%2021-$8.68M+20.2%2020-$10.87M+10.6%2019-$12.15M-62.0%2018-$7.50M-14.0%2017-$6.58M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share